news you can use… pete koval, pharmd megan shah, pharmd candidate cone health family medicine july...
TRANSCRIPT
![Page 1: News You Can Use… Pete Koval, PharmD Megan Shah, PharmD Candidate Cone Health Family Medicine July 2015](https://reader036.vdocuments.net/reader036/viewer/2022082710/56649e0c5503460f94af4e77/html5/thumbnails/1.jpg)
News You Can Use…
Pete Koval, PharmD
Megan Shah, PharmD Candidate
Cone Health Family Medicine
July 2015
![Page 2: News You Can Use… Pete Koval, PharmD Megan Shah, PharmD Candidate Cone Health Family Medicine July 2015](https://reader036.vdocuments.net/reader036/viewer/2022082710/56649e0c5503460f94af4e77/html5/thumbnails/2.jpg)
Drug Launched
• Risedronate, generic for Actonel, is now available• Risedronate is used for the treatment and
prevention of osteoporosis and treatment of Paget’s disease.
• Available as 5 mg, 30 mg, and 35 mg tablets
06/2/2015 Pharmacy Times
![Page 3: News You Can Use… Pete Koval, PharmD Megan Shah, PharmD Candidate Cone Health Family Medicine July 2015](https://reader036.vdocuments.net/reader036/viewer/2022082710/56649e0c5503460f94af4e77/html5/thumbnails/3.jpg)
Trial Review
• IMPROVE-IT trial shows cardiac benefit of adding ezetimibe 10 mg to simvastatin 40 mg after ACS• Simvastatin/ezetimibe reduced CV events by
~7% vs. simvastatin monotherapy (NNT=50)• Baseline LDL of 94 mg/dl was reduced to 54
g/dl with simvastatin/ezetimibe and 70 mg/dl with simvastatin alone.
06/4/2015 N Engl J Med
![Page 4: News You Can Use… Pete Koval, PharmD Megan Shah, PharmD Candidate Cone Health Family Medicine July 2015](https://reader036.vdocuments.net/reader036/viewer/2022082710/56649e0c5503460f94af4e77/html5/thumbnails/4.jpg)
Pharmacy Business
• CVS Health bought Target pharmacies and clinics• Target pharmacies will operate under CVS
name inside Target stores.• Target clinics will be rebranded as
MinuteClinic
06/15/2015 NY Times
![Page 5: News You Can Use… Pete Koval, PharmD Megan Shah, PharmD Candidate Cone Health Family Medicine July 2015](https://reader036.vdocuments.net/reader036/viewer/2022082710/56649e0c5503460f94af4e77/html5/thumbnails/5.jpg)
New Indication
• Zomig (zolmitriptan) nasal spray has been FDA approved for treatment of migraines with or without aura in pediatric patients >12 years of age• Previously was only indicated for age >18.• Starting dose for pediatric patients is 2.5 mg
daily with a max dose of 10 mg daily.
06/16/2015 Medscape
![Page 6: News You Can Use… Pete Koval, PharmD Megan Shah, PharmD Candidate Cone Health Family Medicine July 2015](https://reader036.vdocuments.net/reader036/viewer/2022082710/56649e0c5503460f94af4e77/html5/thumbnails/6.jpg)
New Drug Approval
• Kengreal (cangrelor) gained FDA approval to prevent blood clots in patients undergoing PCI• Intravenous antiplatelet drug (P2Y12
inhibitor)• Administered as a 30 mcg/kg bolus injection,
followed by a 4 mcg/kg/min infusion for 2 to 4 hours.
06/22/2015 FDA.gov
![Page 7: News You Can Use… Pete Koval, PharmD Megan Shah, PharmD Candidate Cone Health Family Medicine July 2015](https://reader036.vdocuments.net/reader036/viewer/2022082710/56649e0c5503460f94af4e77/html5/thumbnails/7.jpg)
FDA Warning
• FDA issued a warning of permanent loss of skin color for Daytrana (methylphenidate) patch.• Skin condition is called chemical leukoderma• Time of onset ranges from 2 months to 4
years
06/24/2015 FDA.gov